Emulate, Inc. (US) and CN Bio Innovations Ltd (UK) are Leading Players in the Organ-On-Chip Market
The global organ-on-chip market is expected to reach USD 631,073 thousand by 2029 from USD 123,285 thousand in 2024, at a CAGR of 38.6% during the forecast period. Growth in the organ-on-chip market is mainly driven by factors such as growing emphasis on animal free drug testing, and an increase in the adoption of organ-on-chip technology by pharma and biotech companies for drug discovery and development. However, due to the limited scalability and low throughput of the current organ-on-chip technology, the use of this technology is restricted only to the pre-clinical drug development phase.
The market for Organ-on-chip market is competitive, with key players strategizing to capture large of the market. Prominent players in the market are Emulate, Inc. (US), MIMETAS B.V (Netherlands), Hesperos, Inc. (US), TissUse GmbH (UK), CN Bio Innovations Ltd (UK), Insphero (Switzerland), AlveoliX AG (UK), Dynamic42 GmbH (UK), ? Beonchip (UK), BiomimX S.r.l. (Italy), Fluigent (France), among others.
To know about the assumptions considered for the study download the pdf brochure
Emulate, Inc. (US) is one of the established player in this market. The company contributes significantly to the organ-on-chip market. Additionally, the company also has a strong geographic presence with distribution channels across North America region. Emulate focuses on the development of in-vitro organ-on-chip models that can replicate the in-vivo micro-environment of the organs. However, the company might experience competitive threats owing to the growing number of players in the organ-on-chip market. Major product examples offered by Emulate, Inc. include various organ-on-chip models, consumables, biokits among others.
CN Bio Innovation Ltd (UK) is another key player in the Organ-on-chip market. The company focuses on development of single and multi organ organ-on-chip models. CN Bio aims to enhance its position in the organ-on-chip market through new product launches, partnerships and collaborations with government and private institutes. For instance, in January 2023, Cn Bio Innovation Ltd expanded its collaboration with the US FDA with new research aimed at evaluating multi-organ microphysiological systems and their applications using its PhysioMimix Multi-organ System. However, the company faces competitive threat from other players, such as Emulate, Inc. (US), Insphero AG (UK), Tissuse GmBH (UK) among others, in this market. Organ-on-chip product offered by Cn Bio Innovations Ltd includes PhysioMimix organ-on-chip consumables and models.
MIMETAS B.V. (Netherlands) is also a well-established player in the Organ-on-chip market. The company provides pre and non-seeded organ-on-chip models for drug and chemical testing. Mimetas focuses on strategic partnerships and collaborations to strengthen its position in the market.Through its distributors the company extends it geographic presence to North America and Asia Pacific regions. Major product examples offered by Mimetas B.V. include- OrganoReady, pre-seeded organ-on-chip platform, and OrganoPlates, microfluidic device for culturing organ cells in controlled micro-environment.
TissUse GmBH (UK) is one of the top 10 players in the Organ-on-chip market. The company is specialized in offering multi-organ chips. Its HUMIMIC Chip range of products is a combination of instruments and accessories offered by the company. The company is dominantly operative in the European region. The company received a 3 year funding to progress development of a preclinical human lung-liver-lymph node co-culture on a HUMIMIC Chip in October 2022. Such developments are adding to the overall market growth for organ-on-chip products.
Hesperos, Inc. (US) is one of the top 10 players in the Organ-on-chip market. Hesperos offers human-on-a-chip microfluidic systems for advanced toxicology testing and drug efficacy evaluation in drug discovery. The company has a wide range of products and been focusing on further innovating ion the organ-on-chip technology. In August 2021, the company received ~USD 1.9 million grant from NIH to progress Alzheimer’s research. Such developments are expected to support the company’s growth in the market.
Related Reports:
Organ-On-Chip Market by Organ Type (Liver, Kidney, Intestine, Lung, Heart), Products (Instruments, Consumable, Software), Services (Standard, Custom), Model Type, Application (Toxicology, Drug Discovery, Stem Cell), Purpose - Global Forecast to 2029
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
